Stephen P Ewald Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 3 weeks ago
Stephen P Ewald has an estimated net worth of at least $14.1 million*, as of March 5, 2025. They own shares of MEDP stock. They have sold 39,863 shares of MEDP stock since 2021, for an estimated $9.7 million.
Stephen P Ewald $MEDP SEC Form 4 Insider Trading
Stephen P Ewald has filed a total of 6 insider trades in $MEDP since 2021. Their most recent trade was a purchase of 2 shares, made on Feb 27, 2025. Their largest trade was a sale of 21,850 shares, made on Jul 27, 2023. We estimate that they now own shares of $MEDP, worth an estimated $4.4 million.
Insider Trading at $MEDP
There have been a total of 270 insider trades reported at $MEDP since 2021, with 2.0 million shares purchased and 5.1 million shares sold. The most active insider traders in $MEDP stock have been August J. Troendle, August J. Troendle, and Stephen P Ewald. The most recent trade was a purchase of 2 shares reported by STEPHEN P EWALD (General Counsel & Corp. Secy.), made on Feb 27, 2025.
History of Insider Stock Trades by Stephen P Ewald
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Purchase | 2 | Feb 27, 2025 | Feb. 28, 2025, 5:39 p.m. |
![]() |
Sale | 1,163 | Feb 29, 2024 | March 1, 2024, 5:32 p.m. |
![]() |
Sale | 350 | Mar 01, 2024 | March 1, 2024, 5:32 p.m. |
![]() |
Sale | 21,850 | Jul 27, 2023 | July 31, 2023, 4:41 p.m. |
![]() |
Sale | 6,500 | Oct 27, 2022 | Oct. 31, 2022, 4:38 p.m. |
![]() |
Sale | 10,000 | Oct 26, 2021 | Oct. 27, 2021, 8 p.m. |
$MEDP Executives and Stock Owners with Insider Trades
-
August J. Troendle, CEO
-
August J. Troendle, President & CEO
-
Stephen P Ewald, General Counsel & Corp. Secy.
-
Susan E Burwig, Exec. VP, Operations
-
Jesse J Geiger, President
-
Kevin M. Brady, CFO & Treasurer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.